LabGenomics Co. Ltd (084650) — Cash Flow Reinvestment Rate
LabGenomics Co. Ltd (084650) has a Cash Flow Reinvestment Rate of 14.31x as of December 2023, reinvesting ₩70.98 Billion (capex ₩895.50 Million plus investments ₩-70.09 Billion) from operating cash flow of ₩4.96 Billion. Check 084650 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LabGenomics Co. Ltd Cash Flow Reinvestment Rate (2014–2023)
Historical reinvestment intensity for LabGenomics Co. Ltd across 9 annual periods. Explore 084650 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for LabGenomics Co. Ltd (2014–2023)
Year-by-year capital reinvestment analysis for LabGenomics Co. Ltd. For live market cap and broader valuation context, see 084650 stock market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 47.71x | ₩115.55 Billion | ₩2.42 Billion | ₩5.20 Billion | ▲ +3537.4% |
| 2022 | 1.31x | ₩91.65 Billion | ₩69.87 Billion | ₩38.33 Billion | ▲ +191.0% |
| 2021 | 0.45x | ₩29.46 Billion | ₩65.36 Billion | ₩13.72 Billion | ▲ +189.2% |
| 2020 | 0.16x | ₩7.23 Billion | ₩46.37 Billion | ₩699.21 Million | ▼ -78.3% |
| 2019 | 0.72x | ₩2.29 Billion | ₩3.19 Billion | ₩560.94 Million | ▼ -95.9% |
| 2018 | 17.30x | ₩10.52 Billion | ₩608.03 Million | ₩2.03 Billion | ▲ +766.4% |
| 2016 | 2.00x | ₩5.08 Billion | ₩2.54 Billion | ₩4.08 Billion | ▲ +0.4% |
| 2015 | 1.99x | ₩4.72 Billion | ₩2.38 Billion | ₩4.63 Billion | ▲ +171.6% |
| 2014 | 0.73x | ₩2.30 Billion | ₩3.15 Billion | ₩1.20 Billion | — |